Neurocrine Biosciences
NBIX
#1366
Rank
ยฃ11.63 B
Marketcap
ยฃ116.66
Share price
0.84%
Change (1 day)
17.20%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Number of shares outstanding for Neurocrine Biosciences (NBIX)

Number of shares outstanding as of December 2025 : 99,400,000

According to Neurocrine Biosciences 's latest financial reports and stock price the company's current number of shares outstanding is 99,400,000. At the end of 2025 the company had 99,400,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Neurocrine Biosciences from 1996 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
202599.4 M-0.6%
20240.10 B1.63%
202398.4 M2.18%
202296.3 M1.48%
202194.9 M1.5%
202093.5 M1.41%
201992.2 M1.61%
201890.74 M2.34%
201788.66 M2.06%
201686.87 M0.8%
201586.18 M13.19%
201476.13 M13.06%
201367.34 M1.42%
201266.4 M20.2%
201155.24 M0.74%
201054.84 M40.28%
200939.09 M1.69%
200838.44 M1.2%
200737.99 M0.32%
200637.86 M3.16%
200536.7 M0.77%
200436.42 M13.65%
200332.05 M5.02%
200230.52 M18.23%
200125.81 M17.18%
200022.03 M15.17%
199919.13 M5.22%
199818.18 M13.64%
199716 M-20%
199620 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Repligen
RGEN
56,265,000-43.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
429,027,000 331.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
526,891-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
895,841,000 801.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
1,767,349,878 1,678.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
5,685,000,000 5,619.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
20,074,000-79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
24,492,000-75.36%๐Ÿ‡บ๐Ÿ‡ธ USA